BR0313276A - Formulações de liberação controlada de sabor agradável para animais de companhia - Google Patents

Formulações de liberação controlada de sabor agradável para animais de companhia

Info

Publication number
BR0313276A
BR0313276A BR0313276-5A BR0313276A BR0313276A BR 0313276 A BR0313276 A BR 0313276A BR 0313276 A BR0313276 A BR 0313276A BR 0313276 A BR0313276 A BR 0313276A
Authority
BR
Brazil
Prior art keywords
controlled release
pet
release formulations
friendly
flavor controlled
Prior art date
Application number
BR0313276-5A
Other languages
English (en)
Inventor
Avinash Govind Thombre
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0313276A publication Critical patent/BR0313276A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/20—Shaping or working-up of animal feeding-stuffs by moulding, e.g. making cakes or briquettes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)

Abstract

"FORMULAçõES DE LIBERAçãO CONTROLADA DE SABOR AGRADáVEL PARA ANIMAIS DE COMPANHIA". A invenção diz respeito às composições farmacêuticas de multiparticulados de liberação controlada mastigáveis para animais de companhia e ao método de prepará-las.
BR0313276-5A 2002-08-06 2003-07-28 Formulações de liberação controlada de sabor agradável para animais de companhia BR0313276A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/213,162 US20030175326A1 (en) 2002-03-05 2002-08-06 Palatable controlled-release formulations for companion animals
PCT/IB2003/003319 WO2004014346A1 (en) 2002-08-06 2003-07-28 Palatable controlled-release formulation for companion animals

Publications (1)

Publication Number Publication Date
BR0313276A true BR0313276A (pt) 2005-07-12

Family

ID=31714226

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0313276-5A BR0313276A (pt) 2002-08-06 2003-07-28 Formulações de liberação controlada de sabor agradável para animais de companhia

Country Status (8)

Country Link
US (3) US20030190343A1 (pt)
EP (1) EP1539119A1 (pt)
JP (1) JP2005538128A (pt)
AU (1) AU2003247121A1 (pt)
BR (1) BR0313276A (pt)
CA (1) CA2494699A1 (pt)
MX (1) MXPA05000976A (pt)
WO (1) WO2004014346A1 (pt)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6616942B1 (en) 1999-03-29 2003-09-09 Soft Gel Technologies, Inc. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
US8669282B2 (en) * 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
CO5400144A1 (es) * 2002-03-11 2004-05-31 Novartis Ag Compuestos organicos
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
DE10328666A1 (de) * 2003-06-26 2005-01-13 Bayer Healthcare Ag Tabletten enthaltend Geschmacks-und/oder Aromastoffe
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE102005005446A1 (de) * 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20080089877A1 (en) * 2003-08-14 2008-04-17 Udell Ronald G Super Absorption Coenzyme Q10
US8105583B2 (en) 2003-09-29 2012-01-31 Soft Gel Technologies, Inc. Solubilized CoQ-10
US7169385B2 (en) * 2003-09-29 2007-01-30 Ronald G. Udell Solubilized CoQ-10 and carnitine
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
DE602004018680D1 (de) * 2003-11-26 2009-02-05 Hills Pet Nutrition Inc Verfahren zur verringerung des exkrementgeruchs von heimtieren
DE102004011512B4 (de) * 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
AR048672A1 (es) * 2004-03-22 2006-05-17 Novartis Ag Tabletas de desintegracion que comprenden licarbazepina
EP1579862A1 (en) * 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
US20050220875A1 (en) * 2004-03-31 2005-10-06 Agency For Science, Technology And Research Sustained-release tablet formulation
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
US20060079514A1 (en) * 2004-10-13 2006-04-13 Victory Pharma Incorporated Methods and compositions including methscopolamine bromide
US7332188B2 (en) * 2004-11-22 2008-02-19 T.F.H. Publications, Inc. Animal chew containing fermented soyfood
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
JP5785355B2 (ja) * 2004-11-24 2015-09-30 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 動物における生体異物物質の肝臓クリアランスを改良する方法
CA2590909A1 (en) * 2004-12-16 2006-06-22 Hill's Pet Nutrition, Inc. Methods for enhancing the palatability of food compositions
JP2008525528A (ja) 2004-12-29 2008-07-17 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 動物における学習および／または記憶の衰退を抑制するための方法
CN101128109B (zh) * 2004-12-30 2013-07-03 希尔氏宠物营养品公司 提高老年动物的生活质量的方法
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
CN101128125A (zh) * 2004-12-30 2008-02-20 希尔氏宠物营养品公司 增强动物消费用组合物的适口性的方法
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
EP1855647A4 (en) * 2005-03-04 2010-11-17 Intelgenx Corp DELAYED RELEASE PHARMACEUTICAL ORAL DOSAGE FORM AND METHOD OF MANUFACTURING THE SAME
JP5284087B2 (ja) * 2005-07-14 2013-09-11 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド 動物の生命を延長するための方法
US8492432B2 (en) * 2005-08-17 2013-07-23 Hill's Pet Nutrition, Inc. Methods for the treatment of kidney disease
FR2889910B1 (fr) * 2005-08-25 2012-02-10 Virbac Sa Produit pour la preparation d'aliments supplementes pour animaux
US9833386B2 (en) 2006-03-30 2017-12-05 James D. Welch Method of, and system for smoothing teeth
US10092488B1 (en) 2006-03-30 2018-10-09 Janet M. Wehrli System and method for reducing plaque on teeth
US9498414B1 (en) 2006-03-30 2016-11-22 Janet M. Wehrli System and method for reducing plaque on teeth
GB2437054B (en) * 2006-04-11 2010-09-22 Michael Hilary Burke A process for the preparation of an orally administered unit dose tablet
US20080020022A1 (en) * 2006-06-05 2008-01-24 Udell Ronald G Chewable co-enzyme q-10 capsule
US20080031949A1 (en) * 2006-07-24 2008-02-07 Cima Labs Inc. High dose orally dissolvable/disintegrable lyophilized dosage form
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
US7767248B2 (en) 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
WO2008136016A1 (en) * 2007-05-08 2008-11-13 Medreich Limited A stable controlled release oral solid dosage form composition and a process thereof
DE102007026550A1 (de) 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
US20090011079A1 (en) * 2007-07-02 2009-01-08 Bestsweet, Inc. Hard Coated Confectionary Having A Consumable Soft Chewing Core With An Active And Method For Making Same
EP2214656B1 (en) 2007-10-26 2018-12-05 Avivagen Inc. Compositions and methods for enhancing immune response
US20090123523A1 (en) * 2007-11-13 2009-05-14 G. Coopersmith Llc Pharmaceutical delivery system
TWI391150B (zh) * 2008-01-22 2013-04-01 Taiwan Biotech Co Ltd 腸溶性長效塗覆芯與藥物劑型及其製造方法
NZ586792A (en) 2008-01-25 2012-09-28 Gruenenthal Chemie Tamper resistant controlled release pharmaceutical tablets form having convex and concave surfaces
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
BRPI0912014A2 (pt) 2008-05-09 2019-03-06 Grünenthal GmbH processo para a preparação de uma formulação em pó intermediária e uma forma de dosagem sólida final sob uso de uma etapa de congelamento por atomização
FR2934156B1 (fr) * 2008-07-23 2010-09-24 Virbac Medicament appetissant a administration orale sous forme solide
EP2653161B1 (en) 2008-12-30 2015-10-07 Hill's Pet Nutrition, Inc. Use of lipoic acid for maintaining or increasing bone mineral density in companion animals
AU2009335081B2 (en) * 2008-12-30 2012-12-06 Hill's Pet Nutrition, Inc. Methods for increasing the palatability of companion animal food compositions
WO2010124391A1 (en) 2009-04-30 2010-11-04 Chemaphor Inc. Methods and compositions for improving the health of animals
WO2010132286A1 (en) * 2009-05-12 2010-11-18 Wyeth Llc Orally administered tablet formulation of an antianxiolytic compound
CN102469807A (zh) * 2009-07-14 2012-05-23 希尔氏宠物营养品公司 包括持续释放的硫辛酸的宠物食品组合物及其制造和使用方法
ES2718688T3 (es) 2009-07-22 2019-07-03 Gruenenthal Gmbh Forma de dosificación resistente a la manipulación para opioides sensibles a la oxidación
CA2765971C (en) 2009-07-22 2017-08-22 Gruenenthal Gmbh Hot-melt extruded controlled release dosage form
ES2606227T3 (es) 2010-02-03 2017-03-23 Grünenthal GmbH Preparación de una composición farmacéutica en polvo mediante una extrusora
NZ608865A (en) 2010-09-02 2015-03-27 Gruenenthal Chemie Tamper resistant dosage form comprising an anionic polymer
PE20131102A1 (es) 2010-09-02 2013-10-12 Gruenenthal Chemie Forma de dosificacion resistente a manipulacion que comprende una sal inorganica
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
AU2012249973B2 (en) * 2011-04-29 2016-05-12 Nestec S.A. Methods for increasing the palatability of food compositions
EP2736495B1 (en) 2011-07-29 2017-08-23 Grünenthal GmbH Tamper-resistant tablet providing immediate drug release
SI2736497T1 (sl) 2011-07-29 2017-12-29 Gruenenthal Gmbh Tableta, odporna proti zlorabi, ki zagotavlja takojšnje sproščanje zdravila
JP6117249B2 (ja) 2012-02-28 2017-04-19 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 薬理学的に活性な化合物および陰イオン性ポリマーを含むタンパーレジスタント剤形
EP2825159B1 (en) 2012-03-15 2022-06-22 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
JP6282261B2 (ja) 2012-04-18 2018-02-21 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 不正使用防止および過量放出防止医薬剤形
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
US20140271893A1 (en) * 2013-03-15 2014-09-18 Mcneil-Ppc, Inc. Coated phenylephrine particles and use thereof in pharmaceutical formulations
US20140335139A1 (en) 2013-05-13 2014-11-13 NeuOra Microceuticals, LLC Long lasting breath mint
MX371432B (es) 2013-05-29 2020-01-30 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
AR096439A1 (es) 2013-05-29 2015-12-30 Gruenenthal Gmbh Forma de dosificación resistente al uso indebido que contiene una o más partículas
JP6449871B2 (ja) 2013-07-12 2019-01-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング エチレン−酢酸ビニルポリマーを含有する改変防止剤形
MX2016000727A (es) 2013-07-19 2016-04-13 Boehringer Ingelheim Vetmed Composicion farmaceutica acuosa liquida que contiene derivados de ciclodextrina eterificada con conservante.
CN103549162B (zh) * 2013-11-02 2014-10-08 成都雪樱动物科技实业有限公司 一种新型饲料添加剂及其制备方法
WO2015078891A1 (en) 2013-11-26 2015-06-04 Farmaceutici Formenti S.P.A. Preparation of a powdery pharmaceutical composition by means of cryo-milling
HUE056143T2 (hu) 2013-12-04 2024-01-28 Boehringer Ingelheim Vetmedica Gmbh Pimobendán javított gyógyászati készítményei
EP3142646A1 (en) 2014-05-12 2017-03-22 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
CA2947894C (en) * 2014-05-21 2022-08-23 Pet's Best Life, Llc Pet chew treat having dental efficacy
JP2017516789A (ja) 2014-05-26 2017-06-22 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング エタノール過量放出に対して防護されている多粒子
US20160106121A1 (en) * 2014-10-20 2016-04-21 Sweet Earth Natural Foods Seitan Bacon Product
BR112017021475A2 (pt) 2015-04-24 2018-07-10 Gruenenthal Gmbh forma de dosagem resistente à adulteração (tamper) com liberação imediata e resistência contra extração de solvente
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
US10342646B2 (en) 2015-10-17 2019-07-09 James D. Welch Method of, and system for smoothing teeth
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN107496368A (zh) * 2016-06-14 2017-12-22 游锡火 一种含抗寄生虫药物和诱食剂的犬、猫用丸剂
CN107510669A (zh) * 2016-06-16 2017-12-26 游锡火 一种含有诱食剂的犬、猫用滴丸制剂
CN111065380A (zh) * 2017-08-17 2020-04-24 法国诗华大药厂 口服组合物及其制备方法
BE1025137B1 (nl) * 2017-12-22 2018-11-09 Nutri-Ad International Nv Diervoeder materiaal
CN111214657A (zh) * 2018-11-23 2020-06-02 北京中农华威制药股份有限公司 一种含有诱食剂的犬、猫用软胶囊
US20210068425A1 (en) * 2019-09-06 2021-03-11 Bayer Healthcare Llc Palatable granular veterinary compositions
GB201919441D0 (en) * 2019-12-31 2020-02-12 Devenish Res Development And Innovation Limited A dietary composition comprising an ingredient of interest
CN111228234A (zh) * 2020-01-07 2020-06-05 宋凤香 一种包衣利度安及其制备方法和用途
EP3878424A1 (en) * 2020-03-10 2021-09-15 Curados B.V. Multi-dosage tablet array
CN112220769A (zh) * 2020-08-13 2021-01-15 浙江海正动物保健品有限公司 一种米尔贝肟吡喹酮风味片及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
US4118512A (en) * 1974-03-05 1978-10-03 Eichelburg Robert J Yeast hydrolyzate oral ingesta for animals
GB1598458A (en) * 1977-04-01 1981-09-23 Hoechst Uk Ltd Tableting of microcapsules
DE2841668A1 (de) * 1978-09-25 1980-04-10 Bayer Ag Medikiertes tierfutter auf basis lebermehl
US4806354A (en) * 1984-04-06 1989-02-21 Green James P Health food composition
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4681758A (en) * 1986-05-29 1987-07-21 Phillips Petroleum Company Shaped, flavored articles and method of producing same
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
IL92343A0 (en) * 1988-12-20 1990-07-26 Gist Brocades Nv Granulate for multiparticulate controlled release oral compositions,their preparation and oral pharmaceutical compositions containing them
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5219574A (en) * 1989-09-15 1993-06-15 Cima Labs. Inc. Magnesium carbonate and oil tableting aid and flavoring additive
ATE178794T1 (de) * 1993-01-19 1999-04-15 Warner Lambert Co Stabilisierte, oral anzuwendende zusammensetzung enthaltend die verbindung ci-981 und verfahren
DE69523912T2 (de) * 1994-05-20 2002-06-27 Janssen Pharmaceutica N.V., Beerse Flubendazole-kautabletten für haustiere
US5591456A (en) * 1995-02-10 1997-01-07 Nanosystems L.L.C. Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer
US5674529A (en) * 1995-06-06 1997-10-07 Church & Dwight Co., Inc. Alkalinizing potassium salt controlled release preparations
US5607697A (en) * 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
JP3611456B2 (ja) * 1997-09-30 2005-01-19 日研化学株式会社 テオフィリン徐放性錠剤
DE69901938T3 (de) * 1998-03-06 2012-08-02 Aptalis Pharma S.R.L. Schnell zerfallende tablette
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
EP1125586A4 (en) * 1998-10-26 2003-06-11 Tanabe Seiyaku Co EXTENDED RELEASE PARTICLES
US6541025B1 (en) * 1999-12-30 2003-04-01 Shear/Kershman Laboratories, Inc. Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
US6340471B1 (en) * 1999-12-30 2002-01-22 Alvin Kershman Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
US20020119196A1 (en) * 2000-12-21 2002-08-29 Narendra Parikh Texture masked particles containing an active ingredient
GB0121436D0 (en) * 2001-09-04 2001-10-24 Pfizer Ltd Biomodulated multiparticulate formulations

Also Published As

Publication number Publication date
US20030190343A1 (en) 2003-10-09
CA2494699A1 (en) 2004-02-19
MXPA05000976A (es) 2005-05-16
US20040166157A1 (en) 2004-08-26
US20030175326A1 (en) 2003-09-18
AU2003247121A1 (en) 2004-02-25
JP2005538128A (ja) 2005-12-15
EP1539119A1 (en) 2005-06-15
WO2004014346A1 (en) 2004-02-19

Similar Documents

Publication Publication Date Title
BR0313276A (pt) Formulações de liberação controlada de sabor agradável para animais de companhia
WO2001085664A3 (en) Compounds and methods for regulating bacterial growth and pathogenesis
EP1538919A4 (en) PREMIXING FORMULATIONS COMPRISING INGREDIENTS FOR MILK PRODUCTS
WO2004106279A3 (en) CRYSTALLINE FORM OF β2 ADRENERGIC RECEPTOR AGONIST
BR9507946A (pt) Agente para aumentar a qualidade de conservação de corpos de animais abatidos
BR0311645A (pt) Isomalte de galactosila - procedimento para sua produção e emprego
ES2154336T3 (es) Producto para el cuidado de la piel.
WO2001078683A3 (en) Sustained release formulations comprising growth hormone
TW200616545A (en) Fungicidal compositions
ZA200306234B (en) Phenethanolamine derivatives for treatment of respiratory diseases.
WO2004060310A3 (en) Human growth hormone crystals and methods for preparing them
IL172423A0 (en) Novel formulations for opioid -based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives
WO2006117784A3 (en) Pharmaceutical compositions comprising casein derived peptides and methods of use thereof
BE2016C049I2 (pt)
FR2844514B1 (fr) Produit immunogene stable comprenant des heterocomplexes antigeniques, compositions les contenant et procede de preparation
CR9363A (es) Composiciones para la transmision transmucosa oral de la metformina
WO2004017749A3 (de) Verwendung von astaxanthinhaltigen pflanzen oder pflanzenteilen der gattung tagetes als futtermittel
ITRM20030158A0 (it) Procedimento per la preparazione di prodotti dolciari contenenti materiale floreale.
PT979224E (pt) Composicoes solidas adequadas para administracao oral compostas por l-carnitina ou alcanoil-l-carnitina fuarato de magnesio
DK0774898T3 (da) Fremgangsmåder til at fremstille biocide sammensætninger med forhalet frigørelse
WO2006138431A3 (en) Methods and pharmaceutical formulations for increasing bioavailability
IS5621A (is) Fiskfóður til eldis, form samsetningar, og aðferðtil gjafar
WO2004064843A3 (de) Kombination zur behandlung von schwindel, welche cinnarizin und dimenhydrinat enthält
ITTO20010152V0 (it) Elastico per la legatura di polli e simili animali destinati alla cottura.
WO2002061066A8 (en) Method for producing an enzyme from a novel source

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A, 4A, 5A, 6A E 7A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2064 DE 27/07/2010.